• Working with

    passion, integrity,
    & true innovation

  • Developing

    novel, first-in-class therapeutics

  • Targeting

    major unmet medical needs

  • Changing

    the approach to
    treating cancer

Imetelstat

First-in-class, first-in-clinic,
telomerase inhibitor

 

Telomerase

Learn about our innovative approach to developing a treatment for cancer

 

Geron Announces
Collaboration with Janssen

Click here for important information

 

Geron News

11.7.2016

Geron Announces November Investor Conference Presentation Webcasts

Read More

11.3.2016

Geron Corporation Reports Third Quarter 2016 Financial Results and Recent Events

Read More

11.3.2016

Geron Announces Presentations at American Society of Hematology Annual Meeting

Read More

 

Events

11.30.2016

Geron at Piper Jaffray 28th Annual Healthcare Conference

Listen to Webcast

11.15.2016

Geron at Stifel 2016 Healthcare Conference

Listen to Webcast

11.03.2016

Geron Q3 2016 Conference Call

Listen to Webcast